A Relative Bioavailability Study of Acetaminophen 650 mg Extended Release Gelcaps Under Fed Condition
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The study was conducted as an open label, balanced, randomised, two-treatment, two-period,
two-sequence, single dose, crossover bioavailability study comparing acetaminophen extended
release gelcaps 650 mg (containing acetaminophen 650 mg) of OHM Laboratories Inc. with
TYLENOLÒ arthritis pain caplets 650 mg (containing acetaminophen 650 mg) of McNeil Consumer &
specialty Pharmaceuticals in healthy, adult, human, male subjects under fed condition.